Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals
about
Use of Gastroesophageal Reflux Medications in Premature Infants After NICU Discharge.The Case for Thoughtful prescribing of PPIs in Infants.Use of Reflux Medications in Premature Infants After Hospital Discharge.Effects of Esophageal Acidification on Troublesome Symptoms: An Approach to Characterize True Acid GERD in Dysphagic Neonates.
P2860
Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neonatal Histamine-2 Receptor ...... ed States Children's Hospitals
@en
Neonatal Histamine-2 Receptor ...... d States Children's Hospitals.
@nl
type
label
Neonatal Histamine-2 Receptor ...... ed States Children's Hospitals
@en
Neonatal Histamine-2 Receptor ...... d States Children's Hospitals.
@nl
prefLabel
Neonatal Histamine-2 Receptor ...... ed States Children's Hospitals
@en
Neonatal Histamine-2 Receptor ...... d States Children's Hospitals.
@nl
P2093
P2860
P1476
Neonatal Histamine-2 Receptor ...... ed States Children's Hospitals
@en
P2093
Michael R Stenger
Patricia B Reagan
Sudarshan R Jadcherla
P2860
P304
P356
10.1016/J.JPEDS.2016.03.059
P407
P577
2016-04-21T00:00:00Z